Iordanova A I, Smolkina T V, Nikitin A V
Antibiot Khimioter. 1995 Mar;40(3):16-21.
Multifactor analysis of the norfloxacin action on the primary immune response to the bacterial antigen (EV vaccine fraction 1) and cellular antigen (sheep erythrocytes) in mice was carried out with using a wide variety of the doses and administration times. In the doses corresponding to the average therapeutic ones norfloxacin was shown to have no effect on the humoral immune response to the bacterial and cellular antigens. In the subtherapeutic doses norfloxacin increased it thus mainly stimulating the synthesis of the IgM antibodies. In the doses exceeding the therapeutic ones the antibiotic lowered the antibody content. The diverse type immunoregulatory action of norfloxacin on the content of the IgG and IGM antibodies could be useful in the rational choice of fluoroquinolones for the treatment of patients with selective deficiency of immunoglobulins of various classes.
使用多种剂量和给药时间,对诺氟沙星作用于小鼠对细菌抗原(EV疫苗组分1)和细胞抗原(绵羊红细胞)的初次免疫反应进行了多因素分析。在相当于平均治疗剂量的情况下,诺氟沙星对细菌和细胞抗原的体液免疫反应无影响。在亚治疗剂量下,诺氟沙星增加了这种反应,主要是刺激了IgM抗体的合成。在超过治疗剂量时,抗生素降低了抗体含量。诺氟沙星对IgG和IGM抗体含量的不同类型免疫调节作用,可能有助于合理选择氟喹诺酮类药物来治疗各类免疫球蛋白选择性缺乏的患者。